Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice.

Hintermann E, Bayer M, Conti CB, Fuchs S, Fausther M, Leung PS, Aurrand-Lions M, Taubert R, Pfeilschifter JM, Friedrich-Rust M, Schuppan D, Dranoff JA, Gershwin ME, Manns MP, Imhof BA, Christen U.

J Autoimmun. 2018 Jul;91:83-96. doi: 10.1016/j.jaut.2018.05.001. Epub 2018 May 9.

PMID:
29753567
2.

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol.

Arndtz K, Corrigan M, Rowe A, Kirkham A, Barton D, Fox RP, Llewellyn L, Athwal A, Wilkhu M, Chen YY, Weston C, Desai A, Adams DH, Hirschfield GM; BUTEO trial team.

BMJ Open. 2017 Jul 3;7(6):e015081. doi: 10.1136/bmjopen-2016-015081.

3.

Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.

Trivedi PJ, Tickle J, Vesterhus MN, Eddowes PJ, Bruns T, Vainio J, Parker R, Smith D, Liaskou E, Thorbjørnsen LW, Hirschfield GM, Auvinen K, Hubscher SG, Salmi M, Adams DH, Weston CJ.

Gut. 2018 Jun;67(6):1135-1145. doi: 10.1136/gutjnl-2016-312354. Epub 2017 Apr 20.

4.

H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.

Song Y, Liu C, Liu X, Trottier J, Beaudoin M, Zhang L, Pope C, Peng G, Barbier O, Zhong X, Li L, Wang L.

Hepatology. 2017 Oct;66(4):1183-1196. doi: 10.1002/hep.29209. Epub 2017 Aug 26.

PMID:
28407375
5.

Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.

Wannhoff A, Rupp C, Friedrich K, Knierim J, Flechtenmacher C, Weiss KH, Stremmel W, Gotthardt DN.

Dig Dis Sci. 2017 Feb;62(2):510-516. doi: 10.1007/s10620-016-4370-4. Epub 2016 Dec 9.

PMID:
27943017
6.

Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis.

Peng ZW, Ikenaga N, Liu SB, Sverdlov DY, Vaid KA, Dixit R, Weinreb PH, Violette S, Sheppard D, Schuppan D, Popov Y.

Hepatology. 2016 Jan;63(1):217-32. doi: 10.1002/hep.28274. Epub 2015 Nov 23.

7.

E-cadherin, guardian of liver physiology.

Gonzalez-Sanchez E, Vaquero J, Fouassier L, Chignard N.

Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):3-6. doi: 10.1016/j.clinre.2014.09.008. Epub 2014 Nov 12.

PMID:
25459993
8.

Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis.

Liaskou E, Jeffery LE, Trivedi PJ, Reynolds GM, Suresh S, Bruns T, Adams DH, Sansom DM, Hirschfield GM.

Gastroenterology. 2014 Jul;147(1):221-232.e7. doi: 10.1053/j.gastro.2014.04.003. Epub 2014 Apr 12.

9.

Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases.

Denk G, Omary AJ, Reiter FP, Hohenester S, Wimmer R, Holdenrieder S, Rust C.

Hepatol Res. 2014 Dec;44(13):1286-98. doi: 10.1111/hepr.12304. Epub 2014 Feb 28.

PMID:
24451045
10.

Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis.

Nakagawa H, Hikiba Y, Hirata Y, Font-Burgada J, Sakamoto K, Hayakawa Y, Taniguchi K, Umemura A, Kinoshita H, Sakitani K, Nishikawa Y, Hirano K, Ikenoue T, Ijichi H, Dhar D, Shibata W, Akanuma M, Koike K, Karin M, Maeda S.

Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1090-5. doi: 10.1073/pnas.1322731111. Epub 2014 Jan 6.

11.

Vascular cell adhesion molecule 1 expression by biliary epithelium promotes persistence of inflammation by inhibiting effector T-cell apoptosis.

Afford SC, Humphreys EH, Reid DT, Russell CL, Banz VM, Oo Y, Vo T, Jenne C, Adams DH, Eksteen B.

Hepatology. 2014 May;59(5):1932-43. doi: 10.1002/hep.26965. Epub 2014 Mar 27.

PMID:
24338559
12.

Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.

Thanan R, Pairojkul C, Pinlaor S, Khuntikeo N, Wongkham C, Sripa B, Ma N, Vaeteewoottacharn K, Furukawa A, Kobayashi H, Hiraku Y, Oikawa S, Kawanishi S, Yongvanit P, Murata M.

Free Radic Biol Med. 2013 Dec;65:1464-72. doi: 10.1016/j.freeradbiomed.2013.07.034. Epub 2013 Jul 31.

PMID:
23917144
13.

Mucosal immunity in liver autoimmunity: a comprehensive review.

Trivedi PJ, Adams DH.

J Autoimmun. 2013 Oct;46:97-111. doi: 10.1016/j.jaut.2013.06.013. Epub 2013 Jul 25. Review.

PMID:
23891169
14.

Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD.

Gastroenterology. 2013 Sep;145(3):521-36. doi: 10.1053/j.gastro.2013.06.052. Epub 2013 Jul 1. Review.

15.

Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells.

Berglin L, Björkström NK, Bergquist A.

Scand J Gastroenterol. 2013 Jun;48(6):719-28. doi: 10.3109/00365521.2013.786131.

PMID:
23713804
16.

Primary sclerosing cholangitis: a review and update on therapeutic developments.

Tabibian JH, Lindor KD.

Expert Rev Gastroenterol Hepatol. 2013 Feb;7(2):103-14. doi: 10.1586/egh.12.80. Review.

PMID:
23363260
17.

Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis.

Kawaguchi T, Kaji R, Horiuchi H, Shirono T, Ishida Y, Okabe Y, Itou M, Mitsuyama K, Akiba J, Nakashima O, Yano H, Kage M, Harada M, Sakisaka S, Sata M.

Hepatol Res. 2011 Dec;41(12):1253-9. doi: 10.1111/j.1872-034X.2011.00875.x.

PMID:
22118304
18.

Pathogenesis of primary sclerosing cholangitis.

Pollheimer MJ, Halilbasic E, Fickert P, Trauner M.

Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):727-39. doi: 10.1016/j.bpg.2011.10.009. Review.

19.

Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity.

Liaskou E, Karikoski M, Reynolds GM, Lalor PF, Weston CJ, Pullen N, Salmi M, Jalkanen S, Adams DH.

Hepatology. 2011 Feb;53(2):661-72. doi: 10.1002/hep.24085. Epub 2011 Jan 10.

20.

Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.

Baghdasaryan A, Claudel T, Kosters A, Gumhold J, Silbert D, Thüringer A, Leski K, Fickert P, Karpen SJ, Trauner M.

Gut. 2010 Apr;59(4):521-30. doi: 10.1136/gut.2009.186528.

Supplemental Content

Loading ...
Support Center